Equities

Anika Therapeutics Inc

Anika Therapeutics Inc

Actions
  • Price (EUR)16.10
  • Today's Change0.300 / 1.90%
  • Shares traded3.00
  • 1 Year change-14.81%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 07:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue167156148
OPERATING EXPENSES
Cost of revenue total646365
Selling, general and admin. expenses, total908574
Depreciation/amortization------
Unusual expense(income)6800
Other operating expenses, total00(21)
Total operating expense254176145
Operating income(88)(19)2.62
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(85)(19)2.43
Provision for income taxes(2.66)(3.89)(1.71)
Net income after taxes(83)(15)4.13
Minority interest------
Net income before extra. Items(83)(15)4.13
Total extraordinary items------
Net income(83)(15)4.13
Inc.avail. to common excl. extra. Items(83)(15)4.13
Inc.avail. to common incl. extra. Items(83)(15)4.13
EPS RECONCILIATION
Basic/primary weighted average shares151514
Basic/primary eps excl. extra items(5.64)(1.02)0.29
Basic/primary eps incl. extra items(5.64)(1.02)0.29
Dilution adjustment------
Diluted weighted average shares151515
Diluted eps excl. extra items(5.64)(1.02)0.28
Diluted eps incl. extra items(5.64)(1.02)0.28
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental----0.02
SUPPLEMENTAL INCOME
Depreciation, supplemental6.436.706.50
Total special items69139.51
NORMALISED INCOME
Normalized income before taxes(16)(5.55)12
Effect of special items on income taxes244.623.12
Income tax excluding impact of special items220.731.41
Normalized income after tax(38)(6.28)11
Normalized income avail. to common(38)(6.28)11
Basic normalized EPS(2.57)(0.43)0.73
Diluted normalized EPS(2.57)(0.43)0.72
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.